The Keap1-Nrf2-ARE pathway is closely related to diseases such as central nervous system disease, cardiovascular system disease, liver disease (Cao et al., 2015), lung disease, kidney disease, tumors, etc. (Liu et al., 2015). Here, KEAP1 is linked to lung disorder.